Pages that link to "Q52024302"

The following pages link to Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. (Q52024302):

Displaying 35 items.

• A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction (Q28308294) (← links)
• The neurodevelopmental impact of childhood onset temporal lobe epilepsy on brain structure and function and the risk of progressive cognitive effects (Q30707607) (← links)
• Neuropsychology and temporal lobe epilepsy (Q30927657) (← links)
• Cerebellar atrophy in temporal lobe epilepsy (Q30997102) (← links)
• Posterior fossa malformations and epilepsy (Q33540392) (← links)
• Anticonvulsant blood levels: historical review with a pediatric focus (Q34099870) (← links)
• Cerebellar volume and long-term use of phenytoin (Q34206424) (← links)
• Olivopontocerebellar Atrophy and Friedreich's Ataxia: Neuropsychological Consequences of Bilateral Versus Unilateral Cerebellar Lesions (Q34447261) (← links)
• Deformation-based morphometry of prospective neurodevelopmental changes in new onset paediatric epilepsy (Q34754651) (← links)
• The nature and extent of cerebellar atrophy in chronic temporal lobe epilepsy (Q34765629) (← links)
• GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias (Q34993901) (← links)
• The role of subcortical structures in human epilepsy (Q35093815) (← links)
• Cerebellar atrophy and prognosis after temporal lobe resection (Q36905603) (← links)
• CNS adverse events associated with antiepileptic drugs (Q37242600) (← links)
• Sudden death in a child with epilepsy: potential cerebellar mechanisms? (Q37923823) (← links)
• Can Therapeutic-Range Chronic Phenytoin Administration Cause Cerebellar Ataxia? (Q38400423) (← links)
• Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs (Q38684428) (← links)
• Brain MRI measurements at a term-equivalent age and their relationship to neurodevelopmental outcomes (Q39359145) (← links)
• Opsoclonus - Myoclonus syndrome induced by phenytoin intoxication (Q42917822) (← links)
• Ultrastructure of Purkinje cell perikarya and their dendritic processes in the rat cerebellar cortex in experimental encephalopathy induced by chronic application of valproate (Q43887806) (← links)
• Dendritic, axonal, and spinal pathology of the Purkinje cells and the neurons of the dentate nucleus after long-term phenytoin administration: a case report. (Q44206996) (← links)
• Cortical and hippocampal volume deficits in temporal lobe epilepsy. (Q45933879) (← links)
• Crossed cerebellar diaschisis secondary to refractory frontal seizures in childhood (Q48433698) (← links)
• Cerebellar changes in partial seizures: clinical correlations of quantitative SPECT and MRI analysis (Q48442283) (← links)
• Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma (Q48491202) (← links)
• Cerebellar atrophy after acute phenytoin intoxication (Q48743499) (← links)
• Quantitative cerebral MRI in epileptic patients (Q48838454) (← links)
• Cerebellar hypometabolism in focal epilepsy is related to age of onset and drug intoxication (Q48852596) (← links)
• Prnp gene and cerebellum volume in patients with refractory mesial temporal lobe epilepsy (Q48959053) (← links)
• Changes in balance function with chronic antiepileptic drug therapy: A twin and sibling study (Q50557645) (← links)
• Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up (Q51119840) (← links)
• CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment. (Q55017266) (← links)
• Relação dose-dependente do uso crônico de fenitoína e atrofia cerebelar em pacientes com epilepsia (Q57086645) (← links)
• Patterns of cerebellar atrophy in patients with chronic epilepsy: a quantitative neuropathological study (Q74106991) (← links)
• Dissecting the neuronal vulnerability underpinning Alpers' syndrome: a clinical and neuropathological study (Q90315920) (← links)